Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | LY4170156 |
Synonyms | |
Therapy Description |
Limited information is currently available on LY4170156, a putative antibody-drug conjugate (ADC) targeting folate receptor alpha (FRa) (May 2024). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
LY4170156 | LY-4170156|LY 4170156 | FOLR1-targeted Therapy 24 | Limited information is currently available on LY4170156, a putative antibody-drug conjugate (ADC) targeting folate receptor alpha (FRa) (May 2024). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06400472 | Phase I | LY4170156 | A Study of LY4170156 in Participants With Selected Advanced Solid Tumors | Recruiting | USA | FRA | ESP | AUS | 2 |